Ratan S. Borkar Sells 7,965 Shares of Quidel Corporation (QDEL) Stock

Quidel Corporation (NASDAQ:QDEL) SVP Ratan S. Borkar sold 7,965 shares of the business’s stock in a transaction dated Thursday, November 9th. The shares were sold at an average price of $38.91, for a total value of $309,918.15. Following the transaction, the senior vice president now owns 11,084 shares in the company, valued at approximately $431,278.44. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.

Quidel Corporation (NASDAQ:QDEL) opened at $38.01 on Wednesday. Quidel Corporation has a twelve month low of $18.25 and a twelve month high of $45.55. The company has a current ratio of 6.28, a quick ratio of 5.68 and a debt-to-equity ratio of 0.70.

Quidel Corporation (NASDAQ:QDEL) last posted its earnings results on Wednesday, November 1st. The company reported ($0.16) earnings per share for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.21). Quidel Corporation had a negative return on equity of 2.36% and a negative net margin of 2.33%. The firm had revenue of $50.89 million for the quarter, compared to analysts’ expectations of $50.47 million. During the same quarter last year, the company posted $0.10 EPS. The firm’s revenue was up 3.1% on a year-over-year basis. equities analysts anticipate that Quidel Corporation will post 0.6 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: This article was first published by Week Herald and is the sole property of of Week Herald. If you are viewing this article on another domain, it was illegally stolen and reposted in violation of international copyright laws. The original version of this article can be accessed at https://weekherald.com/2017/11/15/ratan-s-borkar-sells-7965-shares-of-quidel-corporation-qdel-stock.html.

QDEL has been the topic of a number of research analyst reports. Canaccord Genuity restated a “buy” rating and set a $48.00 price target (up previously from $42.00) on shares of Quidel Corporation in a report on Tuesday, September 19th. Barclays PLC restated a “buy” rating and set a $45.00 price target (up previously from $39.00) on shares of Quidel Corporation in a report on Tuesday, September 19th. Raymond James Financial, Inc. reiterated a “buy” rating and set a $47.00 target price (up previously from $41.00) on shares of Quidel Corporation in a report on Tuesday, September 19th. Zacks Investment Research upgraded Quidel Corporation from a “hold” rating to a “buy” rating and set a $30.00 target price on the stock in a report on Tuesday, July 18th. Finally, Piper Jaffray Companies reiterated a “buy” rating and set a $50.00 target price on shares of Quidel Corporation in a report on Friday, November 3rd. Three analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus target price of $48.80.

Several institutional investors have recently bought and sold shares of QDEL. American International Group Inc. grew its stake in shares of Quidel Corporation by 7.1% in the 1st quarter. American International Group Inc. now owns 16,546 shares of the company’s stock worth $375,000 after buying an additional 1,099 shares during the last quarter. Teachers Advisors LLC grew its stake in shares of Quidel Corporation by 4.6% in the 1st quarter. Teachers Advisors LLC now owns 49,537 shares of the company’s stock worth $1,122,000 after buying an additional 2,170 shares during the last quarter. Legal & General Group Plc grew its stake in shares of Quidel Corporation by 4.6% in the 1st quarter. Legal & General Group Plc now owns 6,931 shares of the company’s stock worth $157,000 after buying an additional 306 shares during the last quarter. Vanguard Group Inc. grew its stake in shares of Quidel Corporation by 4.3% in the 1st quarter. Vanguard Group Inc. now owns 2,126,552 shares of the company’s stock worth $48,145,000 after buying an additional 87,995 shares during the last quarter. Finally, Geode Capital Management LLC grew its stake in shares of Quidel Corporation by 3.9% in the 1st quarter. Geode Capital Management LLC now owns 224,463 shares of the company’s stock worth $5,081,000 after buying an additional 8,441 shares during the last quarter. Institutional investors own 84.42% of the company’s stock.

Quidel Corporation Company Profile

Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: immunoassays, molecular assays, virology and specialty products. The Company sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, pharmacies and wellness screening centers.

Insider Buying and Selling by Quarter for Quidel Corporation (NASDAQ:QDEL)

Receive News & Ratings for Quidel Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quidel Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply